Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Gasperini

Showing results (71-80 of 203) with videos related to

Pageof 21
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 21, 2015
Natalizumab discontinuation in patients with multiple sclerosis: Profiling risk and benefits at therapeutic crossroadsLuca Prosperini, Pietro Annovazzi, Marco Capobianco, et al.
Journal of Neurology|October 17, 2025
Efficacy and safety of ublituximab for relapsing multiple sclerosis patients: current evidence and expert opinionPaolo Preziosa, Vincenzo Brescia Morra, Marco Capobianco, et al.
European Journal of Neurology|March 31, 2021
Scoring the 10-year risk of ambulatory disability in multiple sclerosis: the RoAD scoreClaudio Gasperini, Luca Prosperini, Àlex Rovira, et al.
Frontiers in Immunology|December 1, 2017
Modulation of P2X7 Receptor during Inflammation in Multiple SclerosisSusanna Amadio, Chiara Parisi, Eleonora Piras, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 21, 2020
EBV-specific CD8 T lymphocytes and B cells during glatiramer acetate therapy in patients with MSGisella Guerrera, Serena Ruggieri, Mario Picozza, et al.
Scientific Reports|March 1, 2018
FoxP3 isoforms and PD-1 expression by T regulatory cells in multiple sclerosisManolo Sambucci, Francesca Gargano, Veronica De Rosa, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 25, 2020
Minimal evidence of disease activity (MEDA) in relapsing-remitting multiple sclerosisLuca Prosperini, Chiara Mancinelli, Shalom Haggiag, et al.
Immunology Letters|January 14, 2014
CD28 ligation in the absence of TCR stimulation up-regulates IL-17A and pro-inflammatory cytokines in relapsing-remitting multiple sclerosis T lymphocytesCristina Camperio, Michela Muscolini, Elisabetta Volpe, et al.
Journal of Neurology|April 17, 2002
Monthly corticosteroids decrease neutralizing antibodies to IFNbeta1 b: a randomized trial in multiple sclerosisCarlo Pozzilli, Giovanni Antonini, Francesca Bagnato, et al.
Biochimica Et Biophysica Acta|April 15, 2014
Serum lactate as a novel potential biomarker in multiple sclerosisAngela M Amorini, Viviana Nociti, Axel Petzold, et al.
Pageof 21

Showing results (71-80 of 203) with videos related to

Sort By:
Pageof 21
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 21, 2015
Natalizumab discontinuation in patients with multiple sclerosis: Profiling risk and benefits at therapeutic crossroadsLuca Prosperini, Pietro Annovazzi, Marco Capobianco, et al.
Journal of Neurology|October 17, 2025
Efficacy and safety of ublituximab for relapsing multiple sclerosis patients: current evidence and expert opinionPaolo Preziosa, Vincenzo Brescia Morra, Marco Capobianco, et al.
European Journal of Neurology|March 31, 2021
Scoring the 10-year risk of ambulatory disability in multiple sclerosis: the RoAD scoreClaudio Gasperini, Luca Prosperini, Àlex Rovira, et al.
Frontiers in Immunology|December 1, 2017
Modulation of P2X7 Receptor during Inflammation in Multiple SclerosisSusanna Amadio, Chiara Parisi, Eleonora Piras, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 21, 2020
EBV-specific CD8 T lymphocytes and B cells during glatiramer acetate therapy in patients with MSGisella Guerrera, Serena Ruggieri, Mario Picozza, et al.
Scientific Reports|March 1, 2018
FoxP3 isoforms and PD-1 expression by T regulatory cells in multiple sclerosisManolo Sambucci, Francesca Gargano, Veronica De Rosa, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 25, 2020
Minimal evidence of disease activity (MEDA) in relapsing-remitting multiple sclerosisLuca Prosperini, Chiara Mancinelli, Shalom Haggiag, et al.
Immunology Letters|January 14, 2014
CD28 ligation in the absence of TCR stimulation up-regulates IL-17A and pro-inflammatory cytokines in relapsing-remitting multiple sclerosis T lymphocytesCristina Camperio, Michela Muscolini, Elisabetta Volpe, et al.
Journal of Neurology|April 17, 2002
Monthly corticosteroids decrease neutralizing antibodies to IFNbeta1 b: a randomized trial in multiple sclerosisCarlo Pozzilli, Giovanni Antonini, Francesca Bagnato, et al.
Biochimica Et Biophysica Acta|April 15, 2014
Serum lactate as a novel potential biomarker in multiple sclerosisAngela M Amorini, Viviana Nociti, Axel Petzold, et al.
Pageof 21